within a country are both affected by changes in risk factor prevalence and secular trends in breast cancer diagnosis. For example, adaptation of a western lifestyle has been postulated as being one of the primary reasons for higher breast cancer rates in developed countries and for increasing breast cancer incidence among Asian and Asian American women. [2] [3] [4] Delayed childbearing has influenced rates globally and has been associated with particularly large increases observed recently among Hispanic and Hispanic American women. 5, 6 Widespread implementation of screening mammography in the 1980s led to a steady increase in breast cancer diagnoses in most developed countries over the latter decades of the twentieth century. 7 Early detection of tumours by mammography and advances in medical treatment have improved survival such that breast cancer mortality rates previously on the rise in westernized countries have generally become steady during the late 1990s and, in some countries mortality rates have fallen. 1, 8 This report comprehensively Worldwide, breast cancer is the most common cancer diagnosed among women and is the leading cause of cancer deaths. 1 In 2000 alone, more than one million women were diagnosed (22% of all female cancer diagnoses) and 373 000 women died (14% of all cancer deaths among women) of breast cancer. 1 Global differences in incidence rates and fluctuations in rates examines trends and patterns of breast cancer incidence and mortality worldwide over the last three decades.
Materials and methods

Incidence data
We obtained incidence data for the 25-year period summarized in this report from two sources. For the US black and white populations, we used the Surveillance, Epidemiology and End Results (SEER) programme to generate both age-specific and age-adjusted (world standard population) breast cancer incidence rates per 100 000 woman-years. This population-based cancer registry system represents the most reliable source of US incidence statistics, with long-term data available from nine US registries that include about 9.5% of the US population. Incidence data for all other entries, including US Hawaiian Japanese and Puerto Ricans, were abstracted from the International Agency for Research on Cancer (IARC) publication Cancer Incidence in Five Continents (Volumes IV-VIII), covering five time periods : 1973-77, 1978-82, 1983-87, 1988-92, and 1993-97. 9-13 Incidence data in the IARC publications were most often available by region within each country rather than for the country as a whole.
Mortality data
Mortality rates for the same 25-year period, also age-adjusted to the world standard population per 100 000 woman-years, were obtained from SEER for US black and white women and from the World Health Organization (WHO) mortality data bank, 14 for all other countries/ethnic groups. Unlike the incidence rates, mortality rates were based on data from the entire country.
Inclusion criteria
Candidate countries were selected for inclusion in this report based on the quality, completeness, and availability of incidence . In addition, ratios of age-specific incidence rates (1993-97 relative to 1973-77) were calculated by country to further assess whether overall changes in incidence rates were uniform across all ages or more marked for specific age groups. Figures were prepared using a semi-log scale such that a slope of 10Њ indicates a change of 1% per year. 15 Results Rates were lowest among Asians (27.2-36.2). In both time periods, western countries had the highest rates, which were 3-4 times the rates in Asia.
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Over the past three decades, breast cancer incidence rates increased markedly in all 18 countries; however, no clear patterns by geographic location or ethnic origin emerged. Table 1 presents the percentage increases in age-adjusted incidence from 1973-77 to 1993-97; Figure 1 presents ageadjusted incidence trends by geographic location or origin during the 25-year period. Although most countries (10 of 18) experienced 20-40% increase in breast cancer rates from 1973-77 to 1993-97, seven countries experienced increases of Ͼ40%, with the most dramatic increases in Japan (89%) and Finland (81%), and among US Hawaiian Japanese (78%). Rates rose substantially among Puerto Ricans (68%), in contrast to much smaller increases in Colombia (12%). Notably large increases in breast cancer incidence also occurred in Australia (52%), Poland (47%), and Israel (45%). In Hong Kong and Canada increases were Ͻ20%. Table 2 shows the ratio of age-specific incidence rates in 1993-97 relative to 1973-77 for each country. In general, countries that experienced large increases in breast cancer incidence overall also had increases in all age groups. Changes were attributable primarily to increases among women у50 years of age in North America, Northern Europe, Scandinavia, and Oceania. In contrast, rate increases in China were more pronounced among women Ͻ50 years of age.
Two age-specific incidence patterns predominate worldwide as represented in Figure 2 by Japanese (Asian pattern) and US white women. Steep rates of increase are similar prior to 50 years of age, but diverge thereafter. Breast cancer incidence among US white women continues to rise with age, although at an attenuated rate. In contrast, the rates plateau among Japanese women у50 years of age. The patterns generally were constant over the time periods assessed with increases across all age groups among the Japanese and primarily at ages 50 and older among US whites. Rates among Hawaiian Japanese women were more similar to US white women than those of women from their country of origin (Figure 2) . Table 3 presents age-adjusted mortality rates in 17 countries (except India) in 1973-77 and 1993-97; countries are presented in the same order as shown in Table 1 . In all countries, mortality was much lower than incidence. Mortality rates generally paralleled incidence (1993-97), with highest mortality among developed countries and lower mortality in Latin America (9-14/100 000) and Asia (Ͻ10). In recent years, women in Denmark had the highest mortality rate (27.3), which was approximately four times the lowest rate of 7.4 among Japanese women. Although incidence in US white women during 1993-97 was highest in the world, the mortality rate (19.7) ranked ninth: lower than in all other high risk countries except Australia (19.5) and lower than four of seven intermediate risk countries (Canada, England, Italy, and New Zealand). In contrast, the mortality rate among US black women was the second highest in the world (26.0). Contrary to incidence rates, which are on the rise worldwide, mortality rates decreased between 1973-77 and 1993-97 in half of the countries presented in Table 3 , although no clear geographic patterns emerged. Mortality rates declined more than 10% among US white, Canadian, and Swedish women. Although generally steady during the first half of the 25-year period, breast cancer mortality also declined since 1983-88 in England, Switzerland, Australia, and Hong Kong (Figure 3) . In contrast, mortality rates rose substantially among Japanese (49%), Colombian (37%), Polish (21%), and US black women (17%).
Discussion
Breast cancer incidence and mortality varied as much as 4-fold internationally during 1993-1997. North America had the highest incidence of breast cancer; intermediate levels were reported in Western Europe, Oceania, Scandinavia, and Israel; and Eastern Europe, South and Latin America, and Asia had the lowest rates. Countries with intermediate and high incidence rates also had the highest mortality rates, and those with low incidence rates had the lowest mortality rates. Although race and ethnicity are strong predictors of breast cancer, 16 studies assessing determinants of risk for women who migrated from areas of low to high incidence suggest that international differences are social and environmental in addition to hereditary in origin. 3, 4 Much of the variability in global breast cancer rates has been attributed to country-specific differences in the prevalence of risk factors that determine lifetime exposure to oestrogen. Comparatively younger ages at menarche, older ages at first birth and/or menopause, and higher prevalences of postmenopausal obesity have been proposed as explanations for the disparate breast cancer incidence rates among US white (97/100 000) and Asian women (27/100 000). 2,17 Crosscultural differences in height, diet, alcohol consumption, and exogenous oestrogen use are also believed to contribute to international differences, but to a lesser extent. [18] [19] [20] [21] Further augmenting these findings, molecular epidemiological studies have shown that compared with women living in areas of high breast cancer incidence, women from low risk countries have lower plasma oestrogen levels. 22 Age-related patterns of breast cancer incidence also vary between low, intermediate, and high-risk countries, differences which are particularly pronounced after menopause. For example, US breast cancer incidence rates increase ~100-fold GLOBAL TRENDS IN BREAST CANCER 409 between age 30 and 50 years, but the rate of increase is attenuated between ages 50 and 80 years. 23 A steep rate of increase is also evident among pre-menopausal women residing in Asia; however, the post-menopausal rates plateau and even decrease in some countries. The apparently different behaviour of the curves in older ages previously has been attributed to increasing incidence among young birth cohorts in low-risk countries that was expected to persist such that their incidence curve after age 50 would approach that of the high-risk populations. 24 However, we found that these patterns were constant over the periods assessed by this report, suggesting that they may represent true aetiologic differences between breast cancers diagnosed in respective populations. Age-incidence trends seen among Asian women are similar in shape to those reported for oestrogen receptor-negative tumour types in the US 25 and Denmark. 26 The relative incidence of age-adjusted oestrogen receptor-negative tumours is indeed higher in Asian than Western nations. 27, 28 Between 1973 and 1997 breast cancer incidence increased worldwide, although patterns of increase varied with geographic location. In North America, incidence rates rose through the 1980s, but the increases have slowed in the mid1990s. Rates throughout the rest of the world generally increased most dramatically after the mid-1980s and continued to rise. The contributions of changes in breast cancer risk factors to overall incidence trends in these countries has been masked by large artefactual increases resulting from changes in the way breast cancer is diagnosed. 29 Over the last 25 years, breast Figure 2 Age-specific breast cancer incidence rates for US white women generated from nine SEER registries. Rates for US Hawaiian Japanese and Japanese (Miyagi) women abstracted from IARC Cancer Incidence in Five Continents (1993-97, 1983-87, 1973-77) cancer incidence rose ~30% in westernized nations where breast screening programs were implemented in the late 1980s and early 1990s. 7 The marked increases in rates have been attributed to predominately small localized breast tumours diagnosed among peri-menopausal women, 30 precisely the women who experienced the largest corresponding increase in screening mammography. 31, 32 Rates of increase in Asia have been more marked than in other regions. Contrary to the westernized countries, where period effects (screening) are predominately operative, analyses using age-period-cohort modelling showed that a cohort effect (exposures and or risk factors) explained most of the increase in incidence in Asia. 33, 34 The most striking increases in risk were seen among Japanese populations (78%), although large increases in other Asian countries were also noted (29-35%). Influence of westernization on fertility, diet, and an affluent lifestyle have been hypothesized as an explanation for increasing breast cancer rates. 33, 35, 36 Although some evidence of period effects exist, rising utilization of mammography probably has not contributed greatly to the observed increases, since in Asia most breast tumours are detected by physical examination (with the exception of Japan where population screening was implemented in 1987). 7 Increases seen among Latin American and Caribbean countries are attributable to a combination of changes in mammography use and reproductive patterns, namely a shift to later ages at first birth. 5, 6 The contribution of each to increases in breast cancer rates is not easily untangled. Because mammography use among US Hispanics lags behind that of US white women, its contribution to rising breast cancer rates may be more limited than in other westernized countries. 37 This is probably the case for both Puerto Rican and US black women who, compared with US white women, have experienced more marked increases in breast cancer incidence over the last few decades. It is noteworthy that breast cancer risk was lower in Latin American and Caribbean countries summarized in this report; unexplainably high rates in Argentina, Chile, Uruguay, and Southern Brazil are comparable with North America. 38 Although breast cancer incidence is on the rise worldwide, breast cancer mortality has either been stable or decreased in most countries over the same 25-year period. This has contributed to worldwide shift to lower mortality-incidence a Per 100 000 woman-years, age-adjusted to the world standard. Mortality rates were based on data from the entire country (unlike incidence rates summarized in Tables 1 and 2 , which in most cases represented only a region of a particular country). b Relative to the mortality in US whites (country total). ratios between 1973-77 and 1993-97. Mortality rate reductions have been attributed to better early detection, mass implementation of screening programmes in the late 1980s and early 1990s, and improved treatment. 39 In contrast to US white women who had moderate reductions in mortality (12%), US black women experienced an increase in mortality rates (17%) during the same time period. Whether this disparity is due to reduced access to care or diagnosis of tumours with less favourable prognosis is unclear. 40 Ecological studies have also found that menstrual, reproductive, and family history explains some of the international differences in breast cancer mortality. 24 In addition to risk factor prevalence, genetic susceptibility, and secular trends in diagnosis and treatment, some portion of the global breast cancer incidence rate variation may be due to incomplete reporting. In this report we included only countries with high levels of completeness of reporting as well as high levels of histological verification of tumours. Because of the stringency of the inclusion criteria, less affluent nations in underdeveloped parts of the world are underrepresented in this report. Nonetheless, consistent patterns of higher rates in specific regions suggest true differences in underlying breast cancer risk exist worldwide. Country-specific studies correlating ecological data with cancer incidence and mortality may provide additional clues. Ultimately, future epidemiological studies exploring the combined contributions of hereditary and environmental factors are necessary to improve our understanding of breast cancer aetiology and explanations for global differences in incidence and mortality rates. Age-adjusted breast cancer mortality rates for US black and white women generated from nine SEER registries representing 9.5% of the population. Mortality data for all other countries obtained from the World Health Organization mortality data bank (1973-77 to 1993-97) 
